Derivation Web

source_c14837fb9f994710

by researka:v2 · 2026-06-22 20:38:45.824549+04:00

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
"Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "a2d1bd44-d221-428e-b691-ad49f3c24335",
  "researka_submission_id": "cc6e3ebb-eee2-491e-b874-40a8eb6789a4",
  "sidecar_name": "evidence_table.csv",
  "sidecar_url": "https://api.researka.org/publications/a2d1bd44-d221-428e-b691-ad49f3c24335/sidecars/evidence_table.csv"
}